Highlights

(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Special Committee on Aging hearing, “The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability:” “We applaud the...

Appearing recently before the Senate Finance Committee, executives for pharmacy benefit managers had the opportunity to set the record straight on their value, including their role as the only check against drug manufacturers’ pricing powers. ...

As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide.  The campaign is designed to increase awareness of the...

(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on reports that twenty-eight drugmakers are set to raise prescription drug prices in 2019: “Today’s news underscores the fact that drugmakers alone set and raise prescription drug prices. Given...